FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
2,253 letters match. Newest first.
-
DrugsVivioMD Group LLC dba VivioMD
FDA warned VivioMD that its website misbrands compounded semaglutide and tirzepatide by implying VivioMD is the compounder.
Low -
DrugsGlow Medispa, LLC dba Mint Med
FDA warns telehealth seller Mint Med that its website labels falsely suggest it compounds the semaglutide and tirzepatide drugs it sells.
Low -
DrugsNexlife Inc. dba Nexlife
FDA warned Nexlife that its website labels for compounded semaglutide and tirzepatide falsely suggest Nexlife is the compounder.
Low -
DrugsPublic Health Solution LLC dba DrMedHealth
FDA warned DrMedHealth over false website claims that compounded semaglutide and tirzepatide have the same active ingredient as Ozempic and Mounjaro.
Low -
DrugsD&H Medical Services
FDA warned D&H Medical Services that its website falsely suggests its compounded semaglutide and tirzepatide are the same as FDA-approved brand drugs.
Low -
DrugsMomentum Health 360 dba Momentum Health
FDA warned Momentum Health over false claims for compounded semaglutide, tirzepatide, and liraglutide.
Low -
DrugsMedica Weight Loss
FDA warns telehealth seller Medica Weight Loss that its compounded semaglutide and tirzepatide web claims are false and misbrand the drugs.
Medium -
DrugsEzra Holdco LLC dba Ezra
FDA says Ezra's website misbrands compounded semaglutide and tirzepatide by labeling them as Ezra-made when they are not.
Low -
DrugsReady Med
FDA warned Ready Med over website claims that compounded semaglutide and tirzepatide products were FDA-approved or FDA-licensed.
Low -
DrugsFITISH
FDA warned FITISH over misleading website claims for compounded semaglutide and tirzepatide, including labels suggesting it is the compounder.
Low -
DrugsOrderlyMeds LLC dba OrderlyMeds
FDA warned OrderlyMeds over website claims for compounded semaglutide and tirzepatide, saying its labels and 'FDA-licensed pharmacy' claim are misleading.
Low -
DrugsRoen Health, Inc. dba RoenRx
FDA warned RoenRx that its website misbrands compounded semaglutide with misleading approval claims and a company label implying it makes the drug.
Medium -
DrugsJoi and Blokes dba Joi + Blokes
FDA warned telehealth seller Joi + Blokes that its website misbrands compounded semaglutide and tirzepatide with false, misleading claims.
Medium -
DrugsNova Vascular LLC dba NOVARX
FDA warned NOVARX over false website claims that compounded semaglutide and tirzepatide products are FDA-approved or from FDA-approved pharmacies.
Low -
DrugsClover Meds LLC dba Clover Meds
Clover Meds, a telehealth seller, misbranded compounded semaglutide and tirzepatide with false website claims that it makes the drugs and uses 'FDA-licensed' facilities.
Medium -
DrugsMaximus Health, Inc. dba Maximus
FDA warned Maximus Health that its website makes false or misleading claims about compounded semaglutide and tirzepatide.
Low -
DrugsMacau-Union Pharmaceutical Limited
Macau-Union Pharmaceutical failed CGMP and sold unapproved, misbranded Bamboo Pharmacy OTC pain rubs in the U.S.
High risk -
BiologicsBlue Horizon International, LLC
FDA warned Blue Horizon International over unapproved stem cell and exosome biologics marketed for serious diseases without a license.
High risk -
FoodAversa's Italian Bakery
FDA warns Aversa's Italian Bakery over missing food safety plan and undeclared sesame/milk allergens in ready-to-eat rolls.
High risk -
FoodMeta Labs Pharmaceuticals, LLC
FDA warns Meta Labs its supplements are unapproved drugs and have serious manufacturing violations.
High risk -
DrugsGSC Products, LLC
FDA told GSC Products its Sinus Plumber headache nasal spray is an unapproved new drug sold online without FDA approval.
High risk -
DrugsAja Health and Wellness Inc.
FDA warns Aja Health and Wellness that its Aja Migraine Relief nasal spray is an unapproved, misbranded OTC drug.
Medium -
Tobaccogethyppe.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccopouchline.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobacconpouches.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccopouchew.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccovapetrinity.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoSmoker Business
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccosnusguys.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccovapenovaco.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccovape4sale.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsLus Essentials LLC
FDA warned Lus Essentials that its Dr. Yanhee skin treatment and lightening products are unapproved, misbranded drugs and contain high mercury.
High risk -
DrugsLa Crema De Rebeca
La Crema De Rebeca's skin-lightening cream is an unapproved, misbranded drug containing high mercury, FDA warns.
High risk -
DrugsPolleyMed, LLC
FDA says PolleyMed's SaniiSwab nasal swab is an unapproved, misbranded drug sold online with infection-prevention claims and a false FDA approval claim.
High risk -
Tobaccowaterbedsnstuff.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccoct-riecig.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsHarbin Jixianglong Biotech Co., Ltd.
FDA warned Harbin Jixianglong Biotech over CGMP (manufacturing quality rules) failures and misbranded relabeled semaglutide API with false manufacturer labels and missing drug listings.
High risk -
Tobaccoswisschlz.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
FoodOptiHealth Products, Inc.
FDA warned OptiHealth Products over website claims that Super Antioxidant (OPCXtra) is a drug for diseases like diabetes and Alzheimer's.
Low -
BiologicsEstar Technologies Ltd
FDA warns Estar Technologies over selling seven unapproved PRP/PRF device kits in the U.S. without clearance or approval.
High risk -
DrugsProRx LLC
ProRx LLC, an outsourcing facility, made sterile compounded drugs under insanitary conditions and without required 503B eligibility.
High risk -
AnimalThe Fish Aid
FDA warned The Fish Aid it sells unapproved, unlisted antibiotics for aquarium fish and birds without veterinary oversight.
High risk -
AnimalDK Hardware Supply
FDA warns DK Hardware Supply over unapproved, unlisted aquarium-fish antibiotic drugs.
High risk -
Tobaccokadobarofficial.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccovibepixi.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsRay’s Vitamins
FDA says Ray's Vitamins sells "Yeicob Ácido Hialurónico" as a supplement, but it is an unapproved, misbranded drug containing hidden diclofenac and dexamethasone.
High risk -
Drugsibeautistore.com
ibeautistore.com sold Umary hyaluronic acid capsules as a supplement, but FDA found hidden diclofenac, dexamethasone, and omeprazole.
High risk -
Tobaccojadepouch.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DevicesUnetixs Vascular, Inc.
Unetixs Vascular marketed modified ROODRA and 2CP vascular diagnostic devices without required FDA clearance.
High risk -
FoodNature’s Elements, Inc.
Nature's Elements sold supplement powders with disease claims as unapproved drugs and made them with no required manufacturing records, FDA says.
High risk